Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Slind, Luke"'
Autor:
Diggins, Nicole L., Pham, Andrew H., Mitchell, Jennifer, Parkins, Christopher J., Slind, Luke, Turner, Rebekah, Lee, Byeong-Jae, Yurochko, Andrew D., Caposio, Patrizia, Nelson, Jay A., Hancock, Meaghan H.
Publikováno v:
PLoS Pathogens; 12/11/2024, Vol. 20 Issue 12, p1-33, 33p
Autor:
Diggins NL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Pham AH; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Mitchell J; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Parkins CJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Slind L; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Turner R; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Lee BJ; Department of Microbiology & Immunology, Center for Applied Immunology and Pathological Processes, Center for Emerging Viral Threats, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America., Yurochko AD; Department of Microbiology & Immunology, Center for Applied Immunology and Pathological Processes, Center for Emerging Viral Threats, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America., Caposio P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Nelson JA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Hancock MH; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2024 Dec 11; Vol. 20 (12), pp. e1012285. Date of Electronic Publication: 2024 Dec 11.
Autor:
Medica S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA., Denton M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Diggins NL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Kramer-Hansen O; Department of Biomedical Sciences Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark., Crawford LB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Mayo AT; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Perez WD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Daily MA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Parkins CJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Slind LE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Pung LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Weber WC; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA., Jaeger HK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Streblow ZJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Sulgey G; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Kreklywich CN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Alexander T; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Rosenkilde MM; Department of Biomedical Sciences Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark., Caposio P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Hancock MH; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, USA.
Publikováno v:
Journal of virology [J Virol] 2024 Dec 10, pp. e0180124. Date of Electronic Publication: 2024 Dec 10.